Tag Archives: Eli Lilly

Specialty Pharmacy News Roundup: May 2023

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry

Prescryptive Health Partners with Eli Lilly on Insulin Pricing

Prescryptive Health announced a partnership with Eli Lilly and Company on a subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits

Onco360’s Pharmacy Network the Choice for New Oncology Treatments

Onco360, a subsidiary of PharMerica, is one of the nation’s leading providers of Oncology Pharmacy services

John Santilli quoted in Modern Medicine: FDA approves Cyramza in combination with paclitaxel for advanced gastric cancer after prior chemotherapy

“Cyramza, approved earlier this year for stomach cancer, is a key product in Lilly’s oncology portfolio,” said John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries. “With the colorectal cancer market becoming increasingly crowded, Lilly will need to review the pricing strategy for Cyramza to make sure the drug remains competitive […]